Insider Trading Activity PetMed Express, Inc. (NASDAQ:PETS) – Director Sold 2,500 shares of Stock

ME Staff
-
0

Insider Trading Activity For PetMed Express, Inc. (NASDAQ:PETS)

Robert C Schweitzer , Director of PetMed Express, Inc. (NASDAQ:PETS) reportedly Sold 2,500 shares of the company’s stock at an average price of 49.18 for a total transaction amount of $122,950.00 SEC Form

Insider Trading History For PetMed Express, Inc. (NASDAQ:PETS)

  • On 3/6/2013 Ronald J Korn, Director, sold 2,000 with an average share price of $13.50 per share and the total transaction amounting to $27,000.00.View SEC Filing
  • On 7/22/2013 Bruce S Rosenbloom, CFO, sold 6,250 with an average share price of $16.74 per share and the total transaction amounting to $104,625.00.View SEC Filing
  • On 7/31/2013 Frank J Formica, Director, sold 7,000 with an average share price of $16.39 per share and the total transaction amounting to $114,730.00.View SEC Filing
  • On 8/12/2013 Ronald Korn, Director, sold 1,000 with an average share price of $16.18 per share and the total transaction amounting to $16,180.00.View SEC Filing
  • On 8/14/2013 Ronald Korn, Director, sold 1,000 with an average share price of $16.25 per share and the total transaction amounting to $16,250.00.View SEC Filing
  • On 9/11/2013 Bruce S Rosenbloom, CFO, sold 6,666 with an average share price of $16.21 per share and the total transaction amounting to $108,055.86.View SEC Filing
  • On 9/13/2013 Menderes Akdag, CEO, sold 10,000 with an average share price of $17.00 per share and the total transaction amounting to $170,000.00.View SEC Filing

    • Analyst Ratings For PetMed Express, Inc. (NASDAQ:PETS)
    These are 1 Sell Rating, 2 Hold Ratings, 1 Buy Rating .
    The current consensus rating for PetMed Express, Inc. (NASDAQ:PETS) is Hold (Score: 2.00) with a consensus target price of $33.50 , a potential (30.34% downside)

    Analyst Ratings History For PetMed Express, Inc. (NASDAQ:PETS)

    • On 8/16/2016 Credit Suisse Group Reiterated Rating Sell with a price target of $13.00
    • On 7/11/2017 Craig Hallum Downgraded rating Buy to Hold
    • On 7/24/2017 Northcoast Research Upgraded rating Neutral to Buy with a price target of $54.00
    • On 7/26/2017 Noble Financial Reiterated Rating Hold

    Dividend Information For PetMed Express, Inc. (NASDAQ:PETS)
    PetMed Express, Inc. (NASDAQ:PETS) pays an annual dividend of Community Ranking: with a yield of Community Ranking:

    Dividend History For PetMed Express, Inc. (NASDAQ:PETS)

  • On 1/28/2013 PetMed Express, Inc. announced a quarterly dividend of $0.15 4.64% with an ex dividend date of 2/6/2013 which will be payable on 2/22/2013.
  • On 5/3/2013 PetMed Express, Inc. announced a quarterly dividend of $0.15 4.65% with an ex dividend date of 5/13/2013 which will be payable on 5/24/2013.
  • On 7/26/2013 PetMed Express, Inc. announced a quarterly dividend of $0.17 4.16% with an ex dividend date of 8/8/2013 which will be payable on 8/23/2013.
  • On 10/28/2013 PetMed Express, Inc. announced a quarterly dividend of $0.17 4.56% with an ex dividend date of 11/6/2013 which will be payable on 11/22/2013.
  • On 1/30/2014 PetMed Express, Inc. announced a quarterly dividend of $0.17 5.14% with an ex dividend date of 2/10/2014 which will be payable on 2/21/2014.
  • On 5/5/2014 PetMed Express, Inc. announced a quarterly dividend of $0.17 5.22% with an ex dividend date of 5/14/2014 which will be payable on 5/23/2014.
  • On 7/21/2014 PetMed Express, Inc. announced a quarterly dividend of $0.17 4.79% with an ex dividend date of 7/31/2014 which will be payable on 8/15/2014.

    • Recent Trading Activity for PetMed Express, Inc. (NASDAQ:PETS)
    Shares of PetMed Express, Inc. closed the previous trading session at 48.09 down -0.86 -1.76% with 604,809 shares trading hands.